Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|July 22, 2025
Low-amplitude copy number gains shape cancer through known and novel oncogenes with associated therapeutic vulnerabilitiesThomas F Eleveld, Bauke Ylstra, Leendert H J Looijenga
Stem Cell Research & Therapy|April 15, 2025
Chromosome-specific aberrations, rather than general aneuploidy, may drive mouse embryonic stem cell-derived teratoma metastasisJoaquin Montilla-Rojo, Sanne Hillenius, Thomas F Eleveld, et al.
International Journal of Molecular Sciences|July 12, 2025
Yolk Sac Elements in Tumors Derived from Pluripotent Stem Cells: Borrowing Knowledge from Human Germ Cell TumorsMarnix van Soest, Joaquin Montilla-Rojo, Thomas F Eleveld, et al.
Nucleic Acids Research|July 7, 2021
Engineering large-scale chromosomal deletions by CRISPR-Cas9Thomas F Eleveld, Chaimaa Bakali, Paul P Eijk, et al.
Communications Medicine|April 17, 2026
Identification and validation of liquid biopsy-based methylation biomarkers for germ cell tumor subtypesFerdinand W Janssen, Ad J M Gillis, Puck B Gouswaart, et al.
International Journal of Molecular Sciences|November 13, 2021
The Role of TP53 in Cisplatin Resistance in Mediastinal and Testicular Germ Cell TumorsDennis M Timmerman, Thomas F Eleveld, Ad J M Gillis, et al.
Cancer Research|August 18, 2018
RAS-MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in NeuroblastomaThomas F Eleveld, Linda Schild, Jan Koster, et al.
Advanced Biology|January 6, 2025
Depletion of TP53 in Human Pluripotent Stem Cells Triggers Malignant-Like BehaviorJoaquin Montilla-Rojo, Thomas F Eleveld, Marnix van Soest, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2020
Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancersNil A Schubert, Caitlin D Lowery, Guillaume Bergthold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell TumorsDennis M Timmerman, Thomas F Eleveld, Sruthi Sriram, et al.
Pageof 2